Nadim Ahmed
2021
In 2021, Nadim Ahmed earned a total compensation of $38.5M as President and Chief Executive Officer at Cullinan Therapeutics.
Compensation breakdown
Bonus | $699,000 |
---|---|
Option Awards | $37,723,200 |
Salary | $125,000 |
Total | $38,547,200 |
Ahmed received $37.7M in option awards, accounting for 98% of the total pay in 2021.
Ahmed also received $699K in bonus and $125K in salary.
Rankings
In 2021, Nadim Ahmed's compensation ranked 101st out of 12,415 executives tracked by ExecPay. In other words, Ahmed earned more than 99.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 101 out of 12,415 | 99th |
Division Manufacturing | 31 out of 5,508 | 99th |
Major group Chemicals And Allied Products | 10 out of 2,378 | 100th |
Industry group Drugs | 8 out of 2,099 | 100th |
Industry Biological Products, Except Diagnostic Substances | 5 out of 449 | 99th |
Source: SEC filing on April 29, 2022.
Ahmed's colleagues
We found three more compensation records of executives who worked with Nadim Ahmed at Cullinan Therapeutics in 2021.